Published in Am J Otol on July 01, 1992
Etiopathogenesis of cholesteatoma. Eur Arch Otorhinolaryngol (2003) 1.51
Cholesteatoma fibroblasts promote epithelial cell proliferation through overexpression of epiregulin. PLoS One (2013) 0.99
Updates and knowledge gaps in cholesteatoma research. Biomed Res Int (2015) 0.96
Confirmation of mucin in lymphatic vessels of acquired cholesteatoma. Eur Arch Otorhinolaryngol (2005) 0.86
Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma. Eur Arch Otorhinolaryngol (1996) 0.80
Interleukin 1 (IL-1) and IL-1-receptor antagonist (IL-1-RA) in middle ear cholesteatoma: an analysis of protein production and biological activity. Eur Arch Otorhinolaryngol (1996) 0.78
Enhanced epithelial proliferation due to elevated levels of interleukin-1 receptors in middle ear cholesteatomas. Eur Arch Otorhinolaryngol (1997) 0.77
Topical application of 5-fluorouracil on attic cholesteatoma results in downregulation of keratinocyte growth factor and reduction of proliferative activity. Eur Arch Otorhinolaryngol (2008) 0.77
In vivo over-expression of KGF mimic human middle ear cholesteatoma. Eur Arch Otorhinolaryngol (2014) 0.76
Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives. Clin Exp Otorhinolaryngol (2016) 0.75
Isolation and characterization of trypsin-like and chymotrypsin-like proteinases from human cholesteatoma. Eur Arch Otorhinolaryngol (1994) 0.75
Quantitative measurement of m-RNA levels to assess expression of cyclooxygenase-II, inducible nitric oxide synthase and 12-lipoxygenase genes in middle ear cholesteatoma. Eur Arch Otorhinolaryngol (2013) 0.75
Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor. Cell (1993) 3.57
Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. Oncogene (1993) 2.19
Revised Cutaneous Lupus Erythematosus Disease Area and Severity Index (RCLASI): a modified outcome instrument for cutaneous lupus erythematosus. Br J Dermatol (2010) 2.12
Multiple correlations and Bonferroni's correction. Biol Psychiatry (1998) 1.69
Interstitial hypertension in head and neck tumors in patients: correlation with tumor size. Cancer Res (1992) 1.49
Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus. J Virol (1995) 1.45
Sexual practices among patients with borderline personality disorder. Am J Psychiatry (1987) 1.34
Guidelines for the dosage of neuroleptics. I: Chlorpromazine equivalents of orally administered neuroleptics. Int Clin Psychopharmacol (1989) 1.29
Cartilage tissue engineering with novel nonwoven structured biomaterial based on hyaluronic acid benzyl ester. J Biomed Mater Res (1998) 1.25
Capsella embryogenesis: the chalazal proliferating tissue. J Cell Sci (1971) 1.17
Resorbable polyesters in cartilage engineering: affinity and biocompatibility of polymer fiber structures to chondrocytes. J Biomed Mater Res (1996) 1.13
Simple assay of 0.1-1.0 pmol of ATP, ADP, and AMP in single somatic cells using purified luciferin luciferase. Anal Biochem (1981) 1.06
Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastins. Br J Haematol (2001) 1.04
New chromosomal malformation syndromes. I. Partial monosomy 8p. An attempt to establish a new chromosome deletion syndrome. Eur J Pediatr (1977) 0.97
Comparison of two endotracheal tube securement techniques on unplanned extubation, oral mucosa, and facial skin integrity. Heart Lung (1999) 0.97
Distribution of herpes simplex virus type 1 in human geniculate and vestibular ganglia: implications for vestibular neuritis. Ann Neurol (1999) 0.96
Transcriptional regulation of prostate kallikrein-like genes by androgen. Mol Endocrinol (1992) 0.95
Detection of herpes simplex virus type 1 in human vestibular nuclei. Neurology (2000) 0.94
Anti-labyrinthine antibodies in a patient with relapsing polychondritis. Eur Arch Otorhinolaryngol (1999) 0.92
Hyperproliferation-associated keratin expression in human middle ear cholesteatoma. Acta Otolaryngol (1993) 0.91
International collaborative study for the calibration of a proposed reference preparation for thromboplastin, human recombinant, plain. On behalf of the Subcommittee on Control of Anticoagulation. Thromb Haemost (1998) 0.91
Amitriptyline disposition in young and elderly normal men. Clin Pharmacol Ther (1983) 0.90
Capsella embryogenesis: the central cell. J Cell Sci (1973) 0.90
[Clinical and epidemiological data of patients with malignomas of the head and neck]. Laryngorhinootologie (2002) 0.89
Alternating episodes of vestibular nerve excitation and failure. Neurology (1998) 0.89
Functional characterization of middle ear mucosa residues in cholesteatoma samples. Am J Otol (1994) 0.87
Synthetic androgens suppress the transformed phenotype in the human prostate carcinoma cell line LNCaP. Br J Cancer (1991) 0.87
Engineering of cartilage tissue using bioresorbable polymer fleeces and perfusion culture. Acta Otolaryngol (1995) 0.86
Photodynamic therapy in head and neck surgery. J Photochem Photobiol B (1990) 0.86
High-pressure liquid chromatographic determination of amitriptyline and its major metabolites in human whole blood. J Pharm Sci (1982) 0.86
Histological and histomorphometric evaluation of immediate implant placement on a dog model with a new implant surface treatment. Clin Oral Implants Res (2010) 0.85
Possible autocrine growth stimulation of cholesteatoma epithelium by transforming growth factor alpha. Am J Otolaryngol (1993) 0.85
Identification of proliferating keratinocytes in middle ear cholesteatoma using the monoclonal antibody Ki-67. ORL J Otorhinolaryngol Relat Spec (1996) 0.85
Alteration of epidermal differentiation in middle ear cholesteatoma. Am J Otol (1995) 0.84
Screening for the FV:Q506 mutation--evaluation of thirteen plasma-based methods for their diagnostic efficacy in comparison with DNA analysis. Thromb Haemost (1997) 0.84
Epidermal growth factor receptor (EGF-R) in human middle ear cholesteatoma: an analysis of protein production and gene expression. Am J Otol (1996) 0.84
Eosinophil inflammation of the nasal mucosa in allergic and non-allergic rhinitis measured by eosinophil cationic protein levels in native nasal fluid and serum. Clin Exp Allergy (1994) 0.84
[Reconstruction of a malformed external ear by an endoprosthesis of porous polyethylene with an integrated suction system]. Laryngorhinootologie (1993) 0.83
Role of interleukin 6 in epithelial hyperproliferation and bone resorption in middle ear cholesteatomas. Eur Arch Otorhinolaryngol (1996) 0.83
Immunobiological peculiarities of cholesteatoma in children: quantification of epithelial proliferation by MIB1. Laryngoscope (1996) 0.83
Discrepancies between pharmacokinetic studies of amitriptyline. Clin Pharmacokinet (1985) 0.83
Expression of ionotropic glutamate receptor subunit mRNAs by paraventricular corticotropin-releasing factor (CRF) neurons. Neurosci Lett (1996) 0.83
Quantitative analysis of interleukin-1-alpha gene expression in middle ear cholesteatoma. Laryngoscope (1996) 0.83
Immunologically activated cells in aural cholesteatoma. Am J Otolaryngol (1992) 0.82
Clinical utility of LDL-apheresis in the treatment of sudden hearing loss: a prospective, randomized study. Acta Otolaryngol (1999) 0.82
Cogan's syndrome: clinical significance of antibodies against the inner ear and cornea. Acta Otolaryngol (1999) 0.82
Insertion of ventilation tubes into the medical ear: results and complications. A seven-year review. Ann Otol Rhinol Laryngol Suppl (1981) 0.82
[Endoscopic controlled laser lithotripsy in the treatment of sialolithiasis]. Laryngorhinootologie (1990) 0.82
Transcriptional down-regulation of c-myc in human prostate carcinoma cells by the synthetic androgen mibolerone. Br J Cancer (1992) 0.81
Endoscopically-controlled electrohydraulic intracorporeal shock wave lithotripsy (EISL) of salivary stones. J Otolaryngol (1993) 0.81
Differential effects of acute and chronic administration of haloperidol on substance P and enkephalins in diverse rat brain areas. Neuropsychobiology (1986) 0.81
Aberrant expression of epidermal growth factor receptor in aural cholesteatoma. Laryngoscope (1993) 0.81
[Photodynamic therapy with derivatives from hemotoporphyrines for recurrent laryngeal papillomatosis of the children. Early results]. An Otorrinolaringol Ibero Am (1993) 0.81
Differences between circadian and ultradian organization of cortisol and melatonin rhythms during activity and rest. J Clin Endocrinol Metab (1989) 0.80
Genomic sequence of human prostate specific antigen (PSA). Nucleic Acids Res (1989) 0.80
Effect of growth factors on matrix synthesis by human nasal chondrocytes cultured in monolayer and in agar. Eur Arch Otorhinolaryngol (1996) 0.80
[Age determination by dentition with the aid of dental films]. Zahnarztl Mitt (1982) 0.80
[Intra-arterial cisplatin and sequential radiotherapy. Long-term follow-up]. Laryngorhinootologie (1996) 0.80
Effect of carbetocin, a long-acting oxytocin analog on the postpartum uterus. Clin Pharmacol Ther (1992) 0.80
Impact of overall treatment time on local control of slow growing human GL squamous cell carcinoma in nude mice treated by fractionated irradiation. Radiother Oncol (1999) 0.80
Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma. Eur Arch Otorhinolaryngol (1996) 0.80
Purification and biochemical characterization of functional complement factor H from human plasma fractions. Vox Sang (2012) 0.80
[Expression of calgranulin A and B in middle ear cholesteatoma]. Laryngorhinootologie (1995) 0.79
Reward dependence is positively related to urinary monoamines in normal men. Biol Psychiatry (1997) 0.79
A comparison of class II antigenicity of human tracheal allografts stored in cialit and in merthiolate. Laryngoscope (1990) 0.79
Steroid hormone regulation of prostatic acid phosphatase expression in cultured human prostatic carcinoma cells. Biol Chem Hoppe Seyler (1985) 0.79
Day-to-day intraindividual reliability and interindividual differences in monoamines excretion. J Affect Disord (1996) 0.79
[Measurement of temperature and sound pressure in the inner ear during application of the argon-laser (author's transl)]. Laryngol Rhinol Otol (Stuttg) (1981) 0.79
NK1 receptor expression by cholinergic interneurones in human striatum. Neuroreport (1994) 0.79
[Navigation surgery in diseases of the paranasal sinuses]. Laryngorhinootologie (1999) 0.79
Effect of heparin on the red blood cell-to-plasma concentration ratio of diphenylhydantoin and prazosin. Ther Drug Monit (1983) 0.79
Expression of a cell-cycle-associated nuclear antigen (MIB 1) in cholesteatoma and auditory meatal skin. Laryngoscope (1995) 0.78
The lateral cyst of the neck: congenital or acquired? Acta Otolaryngol (1987) 0.78
[Autologous rib cartilage harvesting: operative procedure and postoperative pain reduction]. Laryngorhinootologie (2000) 0.78
Coexpression of dopamine D2 and substance P (neurokinin-1) receptor messenger RNAs by a subpopulation of cholinergic neurons in the rat striatum. Neuroscience (1993) 0.78
[New aspects on the pathogenesis of cholesteatoma: the possible role of immune cell-induced keratinocyte hyperproliferation]. Laryngorhinootologie (1993) 0.78
Inositol monophosphate esterase inhibition by lithium in normal human studies using neuroendocrine tests. Part I. PRL and TSH responses to TRH. Prog Neuropsychopharmacol Biol Psychiatry (1990) 0.78
The pharmacokinetics of lithium in normal humans: expected and unexpected observations in view of basic kinetic principles. Pharmacopsychiatry (1987) 0.78
[Benign lymphoepithelial parotid cysts in patients infected with the human immunodeficiency virus]. An Otorrinolaringol Ibero Am (1991) 0.78
Tissue engineering of autologous cartilage transplants for rhinology. Am J Rhinol (1998) 0.78
Interleukin 1 (IL-1) and IL-1-receptor antagonist (IL-1-RA) in middle ear cholesteatoma: an analysis of protein production and biological activity. Eur Arch Otorhinolaryngol (1996) 0.78
Detection of class II antigens on human nasal cartilage. Am J Otolaryngol (1991) 0.78
[Otorhinolaryngologic manifestations in patients infected by the acquired immunodeficiency virus]. Acta Otorrinolaringol Esp (1991) 0.78
[Transplantation of in vitro cultured cartilage materials: characterization of matrix synthesis]. Laryngorhinootologie (1997) 0.78
[Neuropsychology in occupational rehabilitation: a new field of intervention?]. Rehabilitation (Stuttg) (2007) 0.78
Correlation of vascular morphology with clinical types in cholesteatoma of the middle ear. Am J Otol (1994) 0.78
Ep-CAM--a marker for the detection of disseminated tumor cells in patients suffering from SCCHN. Anticancer Res (1999) 0.78
Tracheal transplantation: demonstration of HLA class II subregion gene products on human trachea. Acta Otolaryngol (1990) 0.78
[A retrospective study of carcinomas of the oral cavity: a preliminary report (author's transl)]. Wien Klin Wochenschr (1980) 0.78
[Somatic gene therapy in squamous epithelial carcinomas of the head-neck area]. Laryngorhinootologie (1996) 0.77